Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 274

1.

Pharmacokinetics and 48-week safety and efficacy of generic ritonavir tablet-boosted atazanavir in HIV-1-infected Thai adults.

Hiransuthikul A, Thammajaruk N, Techatanawat I, Karachot B, Chuasuwan B, Manamuti C, Duereh M, Sawpitiporn M, Sophonphan J, Gatechompol S, Avihingsanon A, Bowonwattanuwong C, Ruxrungtham K; HIV-NAT 223 study team.

Antivir Ther. 2018 Sep 28. doi: 10.3851/IMP3267. [Epub ahead of print]

PMID:
30265243
2.

CD4/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living with HIV.

Han WM, Apornpong T, Kerr SJ, Hiransuthikul A, Gatechompol S, Do T, Ruxrungtham K, Avihingsanon A.

AIDS Res Ther. 2018 Sep 27;15(1):13. doi: 10.1186/s12981-018-0200-4.

3.

Thermoresponsive Bacteriophage Nanocarrier as a Gene Delivery Vector Targeted to the Gastrointestinal Tract.

Namdee K, Khongkow M, Boonrungsiman S, Nittayasut N, Asavarut P, Temisak S, Saengkrit N, Puttipipatkhachorn S, Hajitou A, Ruxrungtham K, Yata T.

Mol Ther Nucleic Acids. 2018 Sep 7;12:33-44. doi: 10.1016/j.omtn.2018.04.012. Epub 2018 May 1.

4.

Loss to follow-up and associated factors of patients in the National AIDS Program in Thailand.

Teeraananchai S, Kerr SJ, Ruxrungtham K, Avihingsanon A, Chaivooth S, Teeraratkul A, Bhakeecheep S, Ongwandee S, Thanprasertsuk S, Law MG.

Antivir Ther. 2018 Mar 27. doi: 10.3851/IMP3233. [Epub ahead of print]

PMID:
29583122
5.

Successful drug desensitization in patients with delayed-type allergic reactions to anti-tuberculosis drugs.

Siripassorn K, Ruxrungtham K, Manosuthi W.

Int J Infect Dis. 2018 Mar;68:61-68. doi: 10.1016/j.ijid.2018.01.006. Epub 2018 Feb 2.

6.

A novel flavanone derivative inhibits dengue virus fusion and infectivity.

Srivarangkul P, Yuttithamnon W, Suroengrit A, Pankaew S, Hengphasatporn K, Rungrotmongkol T, Phuwapraisirisan P, Ruxrungtham K, Boonyasuppayakorn S.

Antiviral Res. 2018 Mar;151:27-38. doi: 10.1016/j.antiviral.2018.01.010. Epub 2018 Feb 3.

PMID:
29360474
7.

Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study.

Pett SL, Kunisaki KM, Wentworth D, Griffin TJ, Kalomenidis I, Nahra R, Montejano Sanchez R, Hodgson SW, Ruxrungtham K, Dwyer D, Davey RT, Wendt CH; INSIGHT FLU003 Plus Study Group .

Open Forum Infect Dis. 2017 Oct 25;5(1):ofx228. doi: 10.1093/ofid/ofx228. eCollection 2018 Jan.

8.

Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients.

Rungtivasuwan K, Avihingsanon A, Thammajaruk N, Mitruk S, Burger DM, Ruxrungtham K, Sukasem C, Punyawudho B.

Pharmacogenomics. 2017 Nov;18(16):1481-1490. doi: 10.2217/pgs-2017-0128. Epub 2017 Oct 24.

PMID:
29061086
9.

The challenges of ending AIDS in Asia: outcomes of the Thai National AIDS Universal Coverage Programme, 2000-2014.

Chaivooth S, Bhakeecheep S, Ruxrungtham K, Teeraananchai S, Kerr SJ, Teeraratkul A, Sirinirund P, Ongwandee S, Avihingsanon A, Benjarattanaporn P, Phanuphak N, Sungkanuparph S, Mekthon S, Phanuphak P.

J Virus Erad. 2017 Oct 1;3(4):192-199.

10.

Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia.

Kanchanatawan B, Hemrungrojn S, Thika S, Sirivichayakul S, Ruxrungtham K, Carvalho AF, Geffard M, Anderson G, Maes M.

Mol Neurobiol. 2018 Jun;55(6):5184-5201. doi: 10.1007/s12035-017-0751-8. Epub 2017 Sep 5.

PMID:
28875464
11.

Prevalence of Persistent Renal Dysfunction in Perinatally HIV-infected Thai Adolescents.

Bunupuradah T, Phupitakphol T, Sophonphan J, Prasitsuebsai W, Anugulruengkitt S, Jantarabenjakul W, Sopa B, Ruxrungtham K, Chanakul A, Puthanakit T; HIV-NAT 015 Study Team.

Pediatr Infect Dis J. 2018 Jan;37(1):66-70. doi: 10.1097/INF.0000000000001684.

PMID:
28719505
12.

Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study.

Pett SL, Amin J, Horban A, Andrade-Villanueva J, Losso M, Porteiro N, Madero JS, Belloso W, Tu E, Silk D, Kelleher A, Harrigan R, Clark A, Sugiura W, Wolff M, Gill J, Gatell J, Clarke A, Ruxrungtham K, Prazuck T, Kaiser R, Woolley I, Alberto Arnaiz J, Cooper D, Rockstroh JK, Mallon P, Emery S; MARCH study group.

HIV Med. 2018 Jan;19(1):65-71. doi: 10.1111/hiv.12532. Epub 2017 Jul 13.

PMID:
28703491
13.

Efficacy and safety of a once-daily single-tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral-naïve and experienced HIV-1-infected Thai adults.

Avihingsanon A, Maek-A-Nantawat W, Gatechompol S, Sapsirisavat V, Thiansanguankul W, Sophonphan J, Thammajaruk N, Ubolyam S, Burger DM, Ruxrungtham K.

Int J Infect Dis. 2017 Aug;61:89-96. doi: 10.1016/j.ijid.2017.06.009. Epub 2017 Jun 13.

14.

Attrition and Mortality of Children Receiving Antiretroviral Treatment through the Universal Coverage Health Program in Thailand.

Teeraananchai S, Kerr SJ, Puthanakit T, Bunupuradah T, Ruxrungtham K, Chaivooth S, Law MG, Chokephaibulkit K.

J Pediatr. 2017 Sep;188:210-216.e1. doi: 10.1016/j.jpeds.2017.05.035. Epub 2017 Jun 9.

PMID:
28606372
15.

Safety, Pharmacokinetics, and Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment-Naive HIV-Infected Subjects in a Phase 2 Randomized, Controlled Study.

Steens JM, Scherrer D, Gineste P, Barrett PN, Khuanchai S, Winai R, Ruxrungtham K, Tazi J, Murphy R, Ehrlich H.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e00545-17. doi: 10.1128/AAC.00545-17. Print 2017 Jul.

16.

First-Line Antiretroviral Treatment Outcomes and Durability in HIV-Infected Children Treated Through the Universal Coverage Health Program in Thailand.

Teeraananchai S, Bunupuradah T, Puthanakit T, Kerr SJ, Ruxrungtham K, Chaivooth S, Bhakeecheep S, Law MG, Chokephaibulkit K.

J Acquir Immune Defic Syndr. 2017 Jun 1;75(2):219-225. doi: 10.1097/QAI.0000000000001351.

PMID:
28498146
17.

Real-Life Clinical Practice of Using the Xpert MTB/RIF Assay in Thailand.

Kawkitinarong K, Suwanpimolkul G, Kateruttanakul P, Manosuthi W, Ubolyam S, Sophonphan J, Avihingsanon A, Ruxrungtham K.

Clin Infect Dis. 2017 May 15;64(suppl_2):S171-S178. doi: 10.1093/cid/cix151.

PMID:
28475796
18.

Utility of urine lipoarabinomannan (LAM) in diagnosing tuberculosis and predicting mortality with and without HIV: prospective TB cohort from the Thailand Big City TB Research Network.

Suwanpimolkul G, Kawkitinarong K, Manosuthi W, Sophonphan J, Gatechompol S, Ohata PJ, Ubolyam S, Iampornsin T, Katerattanakul P, Avihingsanon A, Ruxrungtham K.

Int J Infect Dis. 2017 Jun;59:96-102. doi: 10.1016/j.ijid.2017.04.017. Epub 2017 Apr 27.

19.

New-onset diabetes in HIV-treated adults: predictors, long-term renal and cardiovascular outcomes.

Putcharoen O, Wattanachanya L, Sophonphan J, Siwamogsatham S, Sapsirisavat V, Gatechompol S, Phonphithak S, Kerr SJ, Chattranukulchai P, Avihingsanon Y, Ruxrungtham K, Avihingsanon A; HIV-NAT 006 team.

AIDS. 2017 Jul 17;31(11):1535-1543. doi: 10.1097/QAD.0000000000001496.

PMID:
28398958
20.

Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation.

Kanchanatawan B, Sirivichayakul S, Ruxrungtham K, Carvalho AF, Geffard M, Anderson G, Maes M.

Mol Neurobiol. 2018 Mar;55(3):2214-2226. doi: 10.1007/s12035-017-0465-y. Epub 2017 Mar 14.

PMID:
28290151
21.

Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway.

Kanchanatawan B, Sirivichayakul S, Thika S, Ruxrungtham K, Carvalho AF, Geffard M, Anderson G, Noto C, Ivanova R, Maes M.

Metab Brain Dis. 2017 Aug;32(4):1003-1016. doi: 10.1007/s11011-017-9982-7. Epub 2017 Mar 3.

PMID:
28258445
22.

Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid.

Kanchanatawan B, Sirivichayakul S, Ruxrungtham K, Carvalho AF, Geffard M, Ormstad H, Anderson G, Maes M.

Mol Neurobiol. 2018 Feb;55(2):1524-1536. doi: 10.1007/s12035-017-0417-6. Epub 2017 Feb 8.

PMID:
28181189
23.

Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients.

Punyawudho B, Thammajaruk N, Ruxrungtham K, Avihingsanon A.

Int J Antimicrob Agents. 2017 Mar;49(3):327-332. doi: 10.1016/j.ijantimicag.2016.11.019. Epub 2017 Jan 18.

PMID:
28109702
24.

Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses.

Prévost J, Zoubchenok D, Richard J, Veillette M, Pacheco B, Coutu M, Brassard N, Parsons MS, Ruxrungtham K, Bunupuradah T, Tovanabutra S, Hwang KK, Moody MA, Haynes BF, Bonsignori M, Sodroski J, Kaufmann DE, Shaw GM, Chenine AL, Finzi A.

J Virol. 2017 Mar 13;91(7). pii: e02452-16. doi: 10.1128/JVI.02452-16. Print 2017 Apr 1.

25.

Life expectancy after initiation of combination antiretroviral therapy in Thailand.

Teeraananchai S, Chaivooth S, Kerr SJ, Bhakeecheep S, Avihingsanon A, Teeraratkul A, Sirinirund P, Law MG, Ruxrungtham K.

Antivir Ther. 2017;22(5):393-402. doi: 10.3851/IMP3121. Epub 2017 Jan 5.

PMID:
28054931
26.

Chronic hepatitis C infection and liver disease in HIV-coinfected patients in Asia.

Durier N, Yunihastuti E, Ruxrungtham K, Kinh NV, Kamarulzaman A, Boettiger D, Widhani A, Avihingsanon A, Huy BV, Syed Omar SF, Sanityoso A, Chittmittrapap S, Dung NT, Pillai V, Suwan-Ampai T, Law M, Sohn AH, Matthews G.

J Viral Hepat. 2017 Mar;24(3):187-196. doi: 10.1111/jvh.12630. Epub 2016 Dec 5.

27.

Clinical practice guideline for diagnosis and management of urticaria.

Kulthanan K, Tuchinda P, Chularojanamontri L, Chanyachailert P, Korkij W, Chunharas A, Wananukul S, Limpongsanurak W, Benjaponpitak S, Wisuthsarewong W, Aunhachoke K, Wessagowit V, Chatchatee P, Wattanakrai P, Jirapongsananuruk O, Klaewsongkram J, Noppakun N, Vichyanond P, Suthipinittharm P, Ruxrungtham K, Singalavanija S, Ngamphaiboon J.

Asian Pac J Allergy Immunol. 2016 Sep;34(3):190-200. Review.

28.

Guidelines to improve urticarial care and the remaining research gaps.

Ruxrungtham K.

Asian Pac J Allergy Immunol. 2016 Sep;34(3):179-180. No abstract available.

29.

Depression and anxiety were low amongst virally suppressed, long-term treated HIV-infected individuals enrolled in a public sector antiretroviral program in Thailand.

Prasithsirikul W, Chongthawonsatid S, Ohata PJ, Keadpudsa S, Klinbuayaem V, Rerksirikul P, Kerr SJ, Ruxrungtham K, Ananworanich J, Avihingsanon A; PROGRESS study team.

AIDS Care. 2017 Mar;29(3):299-305. doi: 10.1080/09540121.2016.1201194. Epub 2016 Aug 10.

PMID:
27683949
30.

Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients.

Punyawudho B, Singkham N, Thammajaruk N, Dalodom T, Kerr SJ, Burger DM, Ruxrungtham K.

Expert Rev Clin Pharmacol. 2016 Dec;9(12):1583-1595. Epub 2016 Sep 23. Review.

PMID:
27626677
31.

Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis.

Teeraananchai S, Kerr SJ, Amin J, Ruxrungtham K, Law MG.

HIV Med. 2017 Apr;18(4):256-266. doi: 10.1111/hiv.12421. Epub 2016 Aug 31.

PMID:
27578404
32.

Alemtuzumab-induced elimination of HIV-1-infected immune cells.

Ruxrungtham K, Sirivichayakul S, Buranapraditkun S, Krause W.

J Virus Erad. 2016 Jan 1;2(1):12-8.

33.

Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial.

Bunupuradah T, Kiertiburanakul S, Avihingsanon A, Chetchotisakd P, Techapornroong M, Leerattanapetch N, Kantipong P, Bowonwatanuwong C, Banchongkit S, Klinbuayaem V, Mekviwattanawong S, Nimitvilai S, Jirajariyavej S, Prasithsirikul W, Munsakul W, Bhakeecheep S, Chaivooth S, Phanuphak P, Cooper DA, Apornpong T, Kerr SJ, Emery S, Ruxrungtham K; LASA Study Group.

Lancet HIV. 2016 Aug;3(8):e343-e350. doi: 10.1016/S2352-3018(16)30010-8. Epub 2016 May 24.

PMID:
27470026
34.

Smoking and projected cardiovascular risk in an HIV-positive Asian regional cohort.

Do TC, Boettiger D, Law M, Pujari S, Zhang F, Chaiwarith R, Kiertiburanakul S, Lee MP, Ditangco R, Wong WW, Nguyen KV, Merati TP, Pham TT, Kamarulzaman A, Oka S, Yunihastuti E, Kumarasamy N, Kantipong P, Choi JY, Ng OT, Durier N, Ruxrungtham K.

HIV Med. 2016 Aug;17(7):542-9. doi: 10.1111/hiv.12358.

36.

High-dose bee venom exposure induces similar tolerogenic B-cell responses in allergic patients and healthy beekeepers.

Boonpiyathad T, Meyer N, Moniuszko M, Sokolowska M, Eljaszewicz A, Wirz OF, Tomasiak-Lozowska MM, Bodzenta-Lukaszyk A, Ruxrungtham K, van de Veen W.

Allergy. 2017 Mar;72(3):407-415. doi: 10.1111/all.12966. Epub 2016 Jul 20.

PMID:
27341567
37.

Pharmaceutical Equivalence of Distributed Generic Antiretroviral (ARV) in Asian Settings: The Cross-Sectional Surveillance Study - PEDA Study.

Sapsirisavat V, Vongsutilers V, Thammajaruk N, Pussadee K, Riyaten P, Kerr S, Avihingsanon A, Phanuphak P, Ruxrungtham K; PEDA study team.

PLoS One. 2016 Jun 20;11(6):e0157039. doi: 10.1371/journal.pone.0157039. eCollection 2016.

38.

Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.

Hiransuthikul A, Rattananupong T, Klaewsongkram J, Rerknimitr P, Pongprutthipan M, Ruxrungtham K.

Allergol Int. 2016 Oct;65(4):432-438. doi: 10.1016/j.alit.2016.04.001. Epub 2016 Apr 28.

39.

Role of Rilpivirine and Etravirine in Efavirenz and Nevirapine-Based Regimens Failure in a Resource-Limited Country: A Cross- Sectional Study.

Teeranaipong P, Sirivichayakul S, Mekprasan S, Ohata PJ, Avihingsanon A, Ruxrungtham K, Putcharoen O.

PLoS One. 2016 Apr 27;11(4):e0154221. doi: 10.1371/journal.pone.0154221. eCollection 2016.

40.

Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study.

Pett SL, Amin J, Horban A, Andrade-Villanueva J, Losso M, Porteiro N, Sierra Madero J, Belloso W, Tu E, Silk D, Kelleher A, Harrigan R, Clark A, Sugiura W, Wolff M, Gill J, Gatell J, Fisher M, Clarke A, Ruxrungtham K, Prazuck T, Kaiser R, Woolley I, Arnaiz JA, Cooper D, Rockstroh JK, Mallon P, Emery S; Maraviroc Switch (MARCH) Study Group.

Clin Infect Dis. 2016 Jul 1;63(1):122-32. doi: 10.1093/cid/ciw207. Epub 2016 Apr 5.

41.

Bone health and HIV in resource-limited settings: a scoping review.

Matovu FK, Wattanachanya L, Beksinska M, Pettifor JM, Ruxrungtham K.

Curr Opin HIV AIDS. 2016 May;11(3):306-25. doi: 10.1097/COH.0000000000000274. Review.

42.

The minor house dust mite allergen Der p 13 is a fatty acid-binding protein and an activator of a TLR2-mediated innate immune response.

Satitsuksanoa P, Kennedy M, Gilis D, Le Mignon M, Suratannon N, Soh WT, Wongpiyabovorn J, Chatchatee P, Vangveravong M, Rerkpattanapipat T, Sangasapaviliya A, Piboonpocanun S, Nony E, Ruxrungtham K, Jacquet A; Mite Allergy Research Cohort (MARC) study team.

Allergy. 2016 Oct;71(10):1425-34. doi: 10.1111/all.12899. Epub 2016 Apr 29.

PMID:
27018864
43.

Strategies to improve the immunogenicity of prM+E dengue virus type-2 DNA vaccine.

Ketloy C, Keelapang P, Prompetchara E, Suphatrakul A, Puttikhunt C, Kasinrerk W, Konishi E, Sittisombut N, Ruxrungtham K.

Asian Pac J Allergy Immunol. 2017 Mar;35(1):11-19. doi: 10.12932/AP0728.

44.

The complex link of the environment on allergic rhinitis and atopic dermatitis.

Ruxrungtham K.

Asian Pac J Allergy Immunol. 2016 Mar;34(1):1-2. No abstract available.

45.

Soluble CD163 and monocyte populations in response to antiretroviral therapy and in relationship with neuropsychological testing among HIV-infected children.

Ananworanich J, Kerr SJ, Jaimulwong T, Vibol U, Hansudewechakul R, Kosalaraksa P, Ngampiyaskul C, Kanjanavanit S, Wongsawat J, Luesomboon W, Apornpong T, Soulas C, Paul R, Ruxrungtham K, Puthanakit T.

J Virus Erad. 2015;1(3):196-202. Epub 2015 Jun 30.

46.

Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma.

Chantaphakul H, Ruxrungtham K.

Expert Opin Pharmacother. 2016;17(5):631-42. doi: 10.1517/14656566.2016.1145659. Epub 2016 Feb 15. Review.

PMID:
26799114
47.

The House Dust Mite Major Allergen Der p 23 Displays O-Glycan-Independent IgE Reactivities but No Chitin-Binding Activity.

Soh WT, Le Mignon M, Suratannon N, Satitsuksanoa P, Chatchatee P, Wongpiyaboron J, Vangveravong M, Rerkpattanapipat T, Sangasapaviliya A, Nony E, Piboonpocanun S, Ruxrungtham K, Jacquet A; Mite Allergy Research Cohort (MARC) Study Team.

Int Arch Allergy Immunol. 2015;168(3):150-60. doi: 10.1159/000442176. Epub 2016 Jan 21.

48.

Brief Report: Seminal Plasma Anti-HIV Antibodies Trigger Antibody-dependent Cellular Cytotoxicity: Implications for HIV Transmission.

Parsons MS, Madhavi V, Ana-Sosa-Batiz F, Center RJ, Wilson KM, Bunupuradah T, Ruxrungtham K, Kent SJ.

J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):17-23. doi: 10.1097/QAI.0000000000000804.

PMID:
26761269
49.

Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial.

Cooper DA, Cordery DV, Zajdenverg R, Ruxrungtham K, Arastéh K, Bergmann F, Neto JL, Scherer J, Chaves RL, Robinson P; study team.

PLoS One. 2016 Jan 5;11(1):e0144917. doi: 10.1371/journal.pone.0144917. eCollection 2016.

50.

Rationale and clinical utility of the darunavir-cobicistat combination in the treatment of HIV/AIDS.

Putcharoen O, Do T, Avihingsanon A, Ruxrungtham K.

Drug Des Devel Ther. 2015 Oct 23;9:5763-9. doi: 10.2147/DDDT.S63989. eCollection 2015. Review.

Supplemental Content

Loading ...
Support Center